Showing results (851-860 of 918) with videos related to
Sort By:
Pageof 92
Cell|February 18, 2014
Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulationKotaro Ohnishi, Katsunori Semi, Takuya Yamamoto, et al.Cancer Chemotherapy and Pharmacology|July 8, 2020
Chemotherapy-induced neutropenia as a prognostic factor in patients with pancreatic cancer treated with gemcitabine plus nab-paclitaxel: a retrospective cohort studyMotoyasu Kan, Hiroshi Imaoka, Kazuo Watanabe, et al.Investigational New Drugs|May 16, 2014
Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinomaMasafumi Ikeda, Shuichiro Shiina, Kohei Nakachi, et al.Journal of Gastroenterology|May 31, 2024
Definitive chemoradiotherapy induces T-cell-inflamed tumor microenvironment in unresectable locally advanced esophageal squamous cell carcinomaTakumi Habu, Shogo Kumagai, Hideaki Bando, et al.Digestive Diseases and Sciences|August 4, 2023
Diagnostic Performance of Endoscopic Ultrasonography with Water-Filled Balloon Method for Superficial Esophageal Squamous Cell CarcinomaYugo Suzuki, Kosuke Nomura, Daisuke Kikuchi, et al.Revista Brasileira De Cirurgia Cardiovascular : Orgao Oficial Da Sociedade Brasileira De Cirurgia Cardiovascular|December 18, 2013
Factors associated to hypoxemia in patients undergoing coronary artery bypass graftingNatália Pereira dos Santos, Rodrigo Martins Mitsunaga, Daniel Lago Borges, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 7, 2012
Treatment outcome for systemic chemotherapy for recurrent pancreatic cancer after postoperative adjuvant chemotherapyTomoko Katsui Taniyama, Chigusa Morizane, Kohei Nakachi, et al.Journal of Human Genetics|February 1, 2013
Exome sequencing identifies novel rheumatoid arthritis-susceptible variants in the BTNL2Shigeki Mitsunaga, Kazuyoshi Hosomichi, Yuko Okudaira, et al.International Journal of Clinical Oncology|August 9, 2021
A phase II study of FOLFIRINOX with primary prophylactic pegfilgrastim for chemotherapy-naïve Japanese patients with metastatic pancreatic cancerMitsuhito Sasaki, Hideki Ueno, Shuichi Mitsunaga, et al.Clinical Immunology (Orlando, Fla.)|March 16, 2010
Dendritic/pancreatic carcinoma fusions for clinical use: Comparative functional analysis of healthy- versus patient-derived fusionsShigeo Koido, Eiichi Hara, Sadamu Homma, et al.Pageof 92